Morgan Stanley raised the firm’s price target on GE HealthCare (GEHC) to $85 from $80 and keeps an Equal Weight rating on the shares. The firm said the risk-reward for the stock has been updated, noting that Q4 results were better-than-expected. Demand is looking solid for GE HealthCare, with solid order backlog, peer results, and the firm’s hospital CapEx survey suggesting a healthy environment, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results
- GE HealthCare reports Q4 adjusted EPS $1.44, consensus $1.40
- GE HealthCare sees FY26 adjusted EPS $4.95-$5.15, consensus $4.93
- GE HealthCare sees FY26 free cash flow about $1.7B
- Notable companies reporting before tomorrow’s open